Population
Patients with familial combined hyperlipidemia (FCHL) and related syndromes
Design
Review
Authors
Loading...
Does not yet change FCHL management; leaves open targeted genetic investigations into CAD pathways.
Understanding the genetic and molecular heterogeneity of familial combined hyperlipidemia may provide insights into the pathophysiology of coronary artery disease.
Peter O. Kwiterovich (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: